Why the study?
Does Down syndrome alter the biosynthesis of thromboxane A2 and prostacyclin in infants, contributing to pulmonary vascular obstructive disease?
Does Down syndrome alter the biosynthesis of thromboxane A2 and prostacyclin in infants, contributing to pulmonary vascular obstructive disease?
Infants with Down syndrome exhibit an imbalance in vasoactive eicosanoid biosynthesis favoring vasoconstriction, which may explain their rapid progression of pulmonary vascular obstructive disease when a left-to-right shunt is present.
Answers are grounded in this paper and cite their sources.
Supports hypothesis of eicosanoid imbalance in Down syndrome; hypothesis-generating for pulmonary vascular disease and requires prospective confirmation.
Patients with Down syndrome (DS) and a left-to-right shunt often develop early severe pulmonary hypertension (PH) and pulmonary vascular obstructive disease (PVOD); the pathophysiological mechanisms underlying the development of these complications are yet to be determined. To investigate the mechanisms, we evaluated the biosynthesis of thromboxane (TX) A(2) and prostacyclin (PGI(2)) in four groups of infants, cross-classified as shown below, by measuring the urinary excretion levels of 11-dehydro-TXB(2) and 2,3-dinor-6-keto-PGF(1alpha): DS infants with a left-to-right shunt and PH (D-PH, n = 18), DS infants without congenital heart defect (D-C, n = 8), non-DS infants with a left-to-right shunt and PH (ND-PH, n = 12), and non-DS infants without congenital heart defect (ND-C, n = 22). The urinary excretion ratios of 11-dehydro-TXB(2) to 2,3-dinor-6-keto-PGF(1alpha) in the D-PH, D-C, ND-PH, and ND-C groups were 7.69, 4.71, 2.10, and 2.27, respectively. The ratio of 11-dehydro-TXB(2) to 2,3-dinor-6-keto-PGF(1alpha) was higher in the presence of DS (P < 0.001), independently of the presence of PH (P = 0.297). The predominant biosynthesis of TXA(2) over PGI(2), leading to vasoconstriction, was observed in DS infants, irrespective of the presence/absence of PH. This imbalance in the biosynthesis of vasoactive eicosanoids may account for the rapid progression of PVOD in DS infants with a left-to-right shunt.
No takes yet. Share an insight, caveat, or question.
Fukushima et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: